Clinical Trials Directory

Trials / Unknown

UnknownNCT00842907

Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage

A Clinical, Laboratorial and Quality of Life Study to Evaluate the Efficacy and Safety of Oral Isotretinoin in the Treatment of Cutaneous Photodamage

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Federal University of São Paulo · Academic / Other
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Accepted

Summary

This is a randomized, comparative, single evaluator-blinded trial to evaluate clinical, histological and immunohistochemical effects of oral isotretinoin plus moisturizer sunscreen as compared to the use of 0,05% tretinoin cream plus moisturizer sunscreen for the treatment of photodamage on face and forearms. Main oral isotretinoin safety parameters will also be analyzed, as well as adverse events related to topical products.

Detailed description

A 24-week study, with 7 or 9 monthly visits, comprising healthy adult volunteers, aged 50 to 75 years will be carried out. The patients should present advanced to severe photodamage on face and forearms. Written informed consent will be obtained from each subject prior to enrollment. Eligible patients will be randomly divided in two groups: A- 10 patients will be treated with oral isotretinoin, 20.0 mg/day, every other day, 15 capsules per month, for 24 weeks, associated with the use of moisturizer broad spectrum sunscreen twice a day. B- 10 patients (controls) will be treated with 0,05% tretinoin cream applied on face and forearms at night and the same moisturizer broad-spectrum sunscreen twice a day. After randomization, laboratory tests will be requested for patients from group A and will be repeated on weeks 4 and 24.

Conditions

Interventions

TypeNameDescription
DRUGoral isotretinoinone 20.0 mg capsule, once a day, every other day, during 24 weeks
DRUGTretinoin0.05% tretinoin cream applied on face and forearms, once a day, in the night, during 24 weeks

Timeline

Start date
2009-05-01
Primary completion
2009-12-01
Completion
2010-08-01
First posted
2009-02-12
Last updated
2010-06-08

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00842907. Inclusion in this directory is not an endorsement.